Announcements Trials
Browse Landscape

Phase

Phase NA 15Phase 4 9Phase 2 7Phase 3 6Phase 1 3Phase 2/3 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 3Unknown 2Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 4OTHER 3

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 7

Conditions

Breast Neoplasms 2760Carcinoma, Non-Small-Cell Lung 2260Prostatic Neoplasms 1425Colorectal Neoplasms 1290Neoplasms 1258Multiple Myeloma 1084Lung Neoplasms 1048Neoplasm Metastasis 994Leukemia, Myeloid, Acute 984Lymphoma 900Melanoma 862Pancreatic Neoplasms 818Ovarian Neoplasms 805Carcinoma, Hepatocellular 782Stomach Neoplasms 753Recurrence 750Leukemia 733Lymphoma, Non-Hodgkin 684Leukemia, Lymphocytic, Chronic, B-Cell 665Lymphoma, Large B-Cell, Diffuse 616Squamous Cell Carcinoma of Head and Neck 615Precursor Cell Lymphoblastic Leukemia-Lymphoma 605Head and Neck Neoplasms 596Brain Neoplasms 592Carcinoma, Renal Cell 586Glioblastoma 572Rectal Neoplasms 563Myelodysplastic Syndromes 522Sarcoma 521Lymphoma, Follicular 516

Interventions

lenvatinib 1adefovir 1Ultrasonography 1Sorafenib 1PHY 906 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 2 × Interventional × Hepatitis B × Clear all
NCT04000737 2025-04-13

YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)

Yiviva Inc.

Phase 2 Completed
62 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular

NCT05195294 2025-03-10

Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC

Lion TCR Pte. Ltd.

Phase 2 Not yet recruiting
55 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular

NCT04710641 2025-03-06

OUTREACH2

Mina Alpha Limited

Phase 2 Completed
8 enrolled
Gastrointestinal

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular

NCT05304234 2024-06-04

Liver Cancer Disparities in American Indian and Alaska Native Persons

University of Washington

Phase 2 Recruiting
200 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular, Liver Cirrhosis

NCT04317248 2020-10-29

"Cocktail" Therapy for Hepatitis B Related Hepatocellular Carcinoma

Third Affiliated Hospital, Sun Yat-Sen University

Phase 2 Unknown
600 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular

NCT00322361 2017-03-16

Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)

Merck Sharp & Dohme LLC

Phase 2 Completed
566 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular

NCT00960518 2009-08-17

TACE

Tongji University

Phase 2 Unknown
216 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡